Future research on CD19 aims to enhance our understanding of its role in B cell biology and its potential as a therapeutic target. Efforts are ongoing to improve CAR-T cell therapies, with the goal of increasing their efficacy and reducing side effects. Additionally, studies are exploring CD19's interactions with other signaling molecules to uncover new therapeutic targets for B cell-related diseases.
